A case of cefditoren‐induced acute generalized exanthematous pustulosis during COVID‐19 pandemics. Severe cutaneous adverse reactions are an issue

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2020-10, Vol.34 (10), p.e537-e539
Hauptverfasser:	Torres‐Navarro, I., Abril‐Pérez, C., Roca‐Ginés, J., Sánchez‐Arráez, J., Botella‐Estrada, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Generalized Exanthematous Pustulosis - diagnosis Acute Generalized Exanthematous Pustulosis - drug therapy Acute Generalized Exanthematous Pustulosis - etiology Adrenal Cortex Hormones - therapeutic use Biopsy, Needle Cephalosporins - adverse effects Cephalosporins - therapeutic use Clinical Laboratory Techniques Coronavirus Infections - diagnosis Coronavirus Infections - drug therapy COVID-19 COVID-19 Testing Covid‐19 Special Forum Diagnosis, Differential Female Follow-Up Studies Humans Immunohistochemistry Letter To The Editor Middle Aged Obesity, Morbid Pandemics - statistics & numerical data Pneumonia, Viral - diagnosis Pneumonia, Viral - drug therapy Severe Acute Respiratory Syndrome - diagnosis Severe Acute Respiratory Syndrome - drug therapy Severity of Illness Index Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!